Marta Alarcón Riquelme has a background in Medicine, Immunology and Genetics. For over 20 years of her research career she has focused in the identification of the genetic basis of SLE as a first building block towards understanding how such genes lead to cellular abnormalities that eventually lead to clinical disease. In this context, animal models provide possibilities where human studies have limitations. A main goal of her research is to understand the mechanisms behind disease pathogenesis, identify new biomarkers for disease, and develop new therapies. Marta Alarcón Riquelme is totally committed to the work for lupus and other autoimmune diseases, and believies that only through careful longitudinal analysis of the patients will we be able to understand this disease. She is focusing importantly on systems biology approaches, -omics data integration and clustering and bioinformatics approaches to the understanding of the disease.